These findings may provide a new insight into the role of circPVT1 as a biomarker for the diagnosis and treatment target of OS.
Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1.